Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Phac2g02868 | ATGGAGAAAAACCATGTTCAGCTTTTGCCTCATCTCACTGTGACACTTCTTGTGATCACTGTTTTGTTTCCTGTGACTGAATGTGCGGCAGTTTCCTCCATCAAGACTGATGTGCAGGCTCTTCTCATGTTCAAAAGGATGATTCAGAACGATCAAGGTGGAGTTTTGTCAGGATGGAAGCTGAATAAGAATCCATGCAGCTGGTATGGAGTCTCTTGCACCCTTGGAAGAGTTACTCAGCTTGATATTAGTGGGAATAATAACCTTGCTGGGACTATATCTCTTGACCCTTTGTCTTCTTTAGATATGTTATCTGTTCTGAAACTGTCTTTGAATTCATTTTCTGTAAATTCTACCTCTTTGCTTCAGCTTCCATATGGTTTGACACAGCTTGATCTATCCTTTGGAGGGGTTACAGGCCCTGTCCCTGAGAACCTTTTCTCCAAGTGTCCAAATCTTGTTGTTGTTAATCTTTCTTACAATAACTTAACAGGTCCTATTCCTGAAAATTTCTTACAAAATTCTGGTAAACTGCAGACACTTGACCTATCTTCCAACAACCTGTCAGGCTCTATTTTTGGCCTGAAAATGGATTGCATTTCCTTGTTGCAACTTGATCTATCTGGAAACCGCTTGTCAGACTCAATTCCACTCTCTTTGTCAAATTGTACCAGCCTTAAAAGTTTGAATTTAGCTAACAATATGATTTCTGGGGAAATTCCCAAAGCTTTGGGTCAGTTAAACAAACTACAGACTCTGGATCTTTCCCGCAACCAACTCACAGGCTGGATCCCTTCTGAATTGGGAAATGCATGTTCTTCCCTTTTAGAGGTTAAACTTTCTTTCAACAACATCTCCGGGTCAATCCCGTCTAGTTTCTCCTCATGCACTTGGCTGCAACTTCTTGACATATCTAACAACAACCTGTCAGGACAGTTAGCAGGGTCAATCTTTCAGAACCTCGGTTCATTGCAGGAACTGAGGCTTGGGAATAATGCTATCACTGGTCAATTTCCATCTTCAATATCTTCCTGCAAAAAGTTGAGGATTGCGGACTTCAGCTCAAACAAAATTTATGGATCTATCCCCAGGGATTTATGTCCAGGGGCAGCCTCACTTGAGGAGCTGAGAATGCCAGACAATCTTATTATAGGTGAAATCCCAGCTGAACTGTCAAAGTGCTCACAGCTGAAGACACTTGATTTTAGTCTGAACTATCTCAATGGTACAATTCCCGATGAGCTTGGACAACTTGAAAATCTTGAGCAGCTGATAGCATGGTTCAATGGTTTGGAAGGAAAAATTCCACCGAAGCTGGGCCAGTGCAAGAATCTTAAGGATCTCATACTGAATAATAATCATCTCACTGGTGGAATTCCCATTGAGTTATTCAATTGCAGCAATCTTGAATGGATATCACTGACAAGCAATGAGCTTAGTGGTGAAATACCGCGTGAGTTTGGTCTCTTGACAAGGTTAGCAGTTCTGCAGCTTGGAAACAACAGCTTGACTGGCGAGATACCAGCAGAGCTAGCGAATTGCAGCAGTTTGGTGTGGTTGGACTTGAACAGCAACAAGCTCACTGGAGAGATTCCATCAAGACTTGGAAGACAGCAAGGAGCAAAATCCTTGTTTGGGATCCTTTCAGGGAACACTTTGGTGTTTGTAAGAAATGTTGGAAACTCATGCAAAGGAGTTGGAGGTTTGTTAGAATTCTCTGGTATTCGACCTGAAAGACTCTTGCAGGTCCCAACATTGAGGACTTGTGACTTCACAAGACTCTATTCTGGTCCTGTCCTCAGCTTGTTCACCAAGTACCAGACTCTTGAGTATCTTGATCTTTCATATAACGAGCTTCGTGGAAAAATCCCAGATGAATTCGGAGACATGGTGGCTTTACAAGTTCTTGAATTATCTCACAATCAGCTATCTGGAGAAATCCCTTCAACACTTGGCCAGCTAAAAAATTTGGGTGTGTTTGATGCATCACACAATAGATTGCAGGGTCATATTCCAGACTCATTCTCAAACCTCTCATTTTTGGTGCAAATTGATTTGTCTCACAATGAGTTAACAGGGCAAATTCCTTCTAGGGGACAACTGAGTACACTTCCAGCTTCCCAGTATGCAAATAACCCTGGCCTTTGCGGTGTACCATTGCCTGACTGCAAGAGTGAAAATAGCCAACCCACAACAAATCCAACTGATGATGCTGGCAAAGGGGGCCATAAAACAGCAACTGCAACATGGGCAAACAGCATTGTAATGGGAATTCTCATCTCTGTTGCTTCTGTGTGTATTTTAATTGTGTGGGCAATTGCAATGCGCGCAAGGAGGAAGGAGGCCGAAGAAGTCAAGATGCTCAATAGCTTACAAGCATGCCATGCTGCTACAACATGGAAAATTGACAAAGAGAAAGAGCCCCTGAGCATCAATGTTGCAACATTTCAGAGGCAGCTGAGGAAACTCAAGTTCTCCCAGCTGATTGAAGCAACTAATGGGTTCTCGGCAGAAAGCCTCATTGGGTGTGGTGGTTTTGGGGAAGTGTTCAAGGCCACACTCAAAGACGGCTCAAGTGTCGCCATAAAGAAGCTCATTCGACTGAGCTGCCAGGGTGATCGAGAATTCATGGCAGAGATGGAAACCTTGGGGAAGATCAAGCACAGAAATCTTGTTCCTCTGTTAGGGTACTGCAAAGTGGGGGAAGAGAGGCTCCTTGTTTATGAATACATGGAGTATGGAAGCTTAGAAGAGATGCTGCATGGGAGAATCAAAACGCGTGATCGCCGCATTTTGACATGGGAAGAAAGGAAAAAGATTGCAAGAGGTGCAGCTAAAGGGCTTTGTTTCCTGCACCATAATTGCATCCCTCACATAATACACAGAGATATGAAGTCAAGCAATGTGCTACTTGACCATGAAATGGAGTCCAGGGTCTCAGATTTTGGAATGGCAAGACTTATAAGTGCCCTTGATACACATCTTAGCGTGAGCACACTGGCAGGAACACCAGGATATGTTCCCCCAGAGTACTACCAAAGCTTCAGGTGCACTGCTAAGGGAGATGTCTACTCATTTGGGGTTGTGATGTTGGAACTGCTTAGTGGTAAACGCCCTACTGACAAGGAGGATTTCGGTGACACCAACTTGGTTGGGTGGGCCAAGATGAAGGTTCGTGAAGGAAAGCAAATGGAAGTAATTGACTCAGACTTGCTTTTGGCCACTCAAGGAACTGATGAGGCAGAAGCCAAAGAAGTGAAGGAGATGATAAGATATTTAGAGATTACTTTGCAGTGTGTTGATGACTTGCCTTCAAGAAGGCCAAACATGTTGCAGGTAGTCGCTATGCTGAGAGAGCTTATGCCTGGATCAACTGATGGAAGCAGCAACAGTGCTTGA | 3399 | 0.4366 | MEKNHVQLLPHLTVTLLVITVLFPVTECAAVSSIKTDVQALLMFKRMIQNDQGGVLSGWKLNKNPCSWYGVSCTLGRVTQLDISGNNNLAGTISLDPLSSLDMLSVLKLSLNSFSVNSTSLLQLPYGLTQLDLSFGGVTGPVPENLFSKCPNLVVVNLSYNNLTGPIPENFLQNSGKLQTLDLSSNNLSGSIFGLKMDCISLLQLDLSGNRLSDSIPLSLSNCTSLKSLNLANNMISGEIPKALGQLNKLQTLDLSRNQLTGWIPSELGNACSSLLEVKLSFNNISGSIPSSFSSCTWLQLLDISNNNLSGQLAGSIFQNLGSLQELRLGNNAITGQFPSSISSCKKLRIADFSSNKIYGSIPRDLCPGAASLEELRMPDNLIIGEIPAELSKCSQLKTLDFSLNYLNGTIPDELGQLENLEQLIAWFNGLEGKIPPKLGQCKNLKDLILNNNHLTGGIPIELFNCSNLEWISLTSNELSGEIPREFGLLTRLAVLQLGNNSLTGEIPAELANCSSLVWLDLNSNKLTGEIPSRLGRQQGAKSLFGILSGNTLVFVRNVGNSCKGVGGLLEFSGIRPERLLQVPTLRTCDFTRLYSGPVLSLFTKYQTLEYLDLSYNELRGKIPDEFGDMVALQVLELSHNQLSGEIPSTLGQLKNLGVFDASHNRLQGHIPDSFSNLSFLVQIDLSHNELTGQIPSRGQLSTLPASQYANNPGLCGVPLPDCKSENSQPTTNPTDDAGKGGHKTATATWANSIVMGILISVASVCILIVWAIAMRARRKEAEEVKMLNSLQACHAATTWKIDKEKEPLSINVATFQRQLRKLKFSQLIEATNGFSAESLIGCGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKVGEERLLVYEYMEYGSLEEMLHGRIKTRDRRILTWEERKKIARGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDHEMESRVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSFGVVMLELLSGKRPTDKEDFGDTNLVGWAKMKVREGKQMEVIDSDLLLATQGTDEAEAKEVKEMIRYLEITLQCVDDLPSRRPNMLQVVAMLRELMPGSTDGSSNSA* | 1133 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Phac2g02868 | 1132 | FunFam | serine/threonine-protein kinase BRI1-like 2 | 911 | 1128 | - | - | |
Phac2g02868 | 1132 | Pfam | Leucine rich repeat | 202 | 260 | IPR001611 | GO:0005515 | |
Phac2g02868 | 1132 | Pfam | Leucine rich repeat | 128 | 188 | IPR001611 | GO:0005515 | |
Phac2g02868 | 1132 | Pfam | Leucine rich repeat | 602 | 643 | IPR001611 | GO:0005515 | |
Phac2g02868 | 1132 | ProSitePatterns | Protein kinases ATP-binding region signature. | 841 | 864 | IPR017441 | GO:0005524 | |
Phac2g02868 | 1132 | SUPERFAMILY | L domain-like | 573 | 719 | - | - | |
Phac2g02868 | 1132 | CDD | STKc_IRAK | 841 | 1120 | - | - | |
Phac2g02868 | 1132 | MobiDBLite | consensus disorder prediction | 722 | 743 | - | - | |
Phac2g02868 | 1132 | Gene3D | Phosphorylase Kinase; domain 1 | 795 | 910 | - | - | |
Phac2g02868 | 1132 | FunFam | serine/threonine-protein kinase BRI1-like 2 | 36 | 148 | - | - | |
Phac2g02868 | 1132 | Gene3D | Transferase(Phosphotransferase) domain 1 | 911 | 1129 | - | - | |
Phac2g02868 | 1132 | SUPERFAMILY | L domain-like | 36 | 311 | - | - | |
Phac2g02868 | 1132 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 959 | 971 | IPR008271 | GO:0004672|GO:0006468 | |
Phac2g02868 | 1132 | Gene3D | Ribonuclease Inhibitor | 36 | 147 | IPR032675 | - | |
Phac2g02868 | 1132 | ProSiteProfiles | Leucine-rich repeat profile. | 201 | 222 | IPR001611 | GO:0005515 | |
Phac2g02868 | 1132 | FunFam | LRR receptor-like serine/threonine-protein kinase | 465 | 539 | - | - | |
Phac2g02868 | 1132 | ProSiteProfiles | Protein kinase domain profile. | 835 | 1121 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Phac2g02868 | 1132 | FunFam | LRR receptor-like serine/threonine-protein kinase ERECTA | 274 | 362 | - | - | |
Phac2g02868 | 1132 | PANTHER | LEUCINE-RICH REPEAT RECEPTOR-LIKE PROTEIN KINASE PXC1 | 202 | 313 | IPR046959 | - | |
Phac2g02868 | 1132 | SUPERFAMILY | RNI-like | 239 | 538 | - | - | |
Phac2g02868 | 1132 | FunFam | LRR receptor-like serine/threonine-protein kinase ERECTA | 193 | 273 | - | - | |
Phac2g02868 | 1132 | FunFam | LRR receptor-like serine/threonine-protein kinase ERECTA | 601 | 723 | - | - | |
Phac2g02868 | 1132 | Pfam | Brassinosteroid receptor island domain | 545 | 603 | IPR045381 | - | |
Phac2g02868 | 1132 | FunFam | LRR receptor-like serine/threonine-protein kinase ERECTA | 363 | 459 | - | - | |
Phac2g02868 | 1132 | SMART | LRR_typ_2 | 247 | 271 | IPR003591 | - | |
Phac2g02868 | 1132 | SMART | LRR_typ_2 | 199 | 223 | IPR003591 | - | |
Phac2g02868 | 1132 | SMART | LRR_typ_2 | 515 | 538 | IPR003591 | - | |
Phac2g02868 | 1132 | SMART | LRR_typ_2 | 418 | 442 | IPR003591 | - | |
Phac2g02868 | 1132 | SMART | LRR_typ_2 | 150 | 174 | IPR003591 | - | |
Phac2g02868 | 1132 | SMART | LRR_typ_2 | 321 | 345 | IPR003591 | - | |
Phac2g02868 | 1132 | SMART | LRR_typ_2 | 630 | 654 | IPR003591 | - | |
Phac2g02868 | 1132 | SMART | LRR_typ_2 | 443 | 466 | IPR003591 | - | |
Phac2g02868 | 1132 | SMART | LRR_typ_2 | 490 | 514 | IPR003591 | - | |
Phac2g02868 | 1132 | SMART | serkin_6 | 835 | 1121 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Phac2g02868 | 1132 | SUPERFAMILY | Protein kinase-like (PK-like) | 816 | 1117 | IPR011009 | - | |
Phac2g02868 | 1132 | Gene3D | Ribonuclease Inhibitor | 148 | 723 | IPR032675 | - | |
Phac2g02868 | 1132 | FunFam | serine/threonine-protein kinase BRI1-like 2 | 796 | 910 | - | - | |
Phac2g02868 | 1132 | MobiDBLite | consensus disorder prediction | 724 | 738 | - | - | |
Phac2g02868 | 1132 | Gene3D | - | 548 | 604 | - | - | |
Phac2g02868 | 1132 | Pfam | Leucine rich repeat N-terminal domain | 35 | 73 | IPR013210 | - | |
Phac2g02868 | 1132 | PRINTS | Leucine-rich repeat signature | 247 | 260 | - | - | |
Phac2g02868 | 1132 | PRINTS | Leucine-rich repeat signature | 178 | 191 | - | - | |
Phac2g02868 | 1132 | Pfam | Protein tyrosine and serine/threonine kinase | 838 | 1116 | IPR001245 | GO:0004672|GO:0006468 | |
Phac2g02868 | 1132 | Pfam | BspA type Leucine rich repeat region (6 copies) | 274 | 382 | IPR026906 | - |
Select | Gene | Chromosome | Start | End | Duplicated_type |
---|---|---|---|---|---|
Phac2g02868 | Phac-Chr2 | 30311103 | 30315129 | Transposed |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Phac2g02868 | 41 | 1120 | Receptor kinase-like Gene Family | AT1G55610 | 49.198 | 0.0 | 1006 |
Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
---|---|---|---|---|---|---|---|
PK | RLK-Pelle_LRR-Xb-1 | Phac2g02868 | PK_Tyr_Ser-Thr | 1.6e-43 | CL0016 |
Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
---|---|---|---|---|---|---|
Phac2g02868 | - | - | gmx:100789959 | 2085.07 |